Neuromodulation Devices
•26 stocks
•
Total Market Cap: Loading...
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (26)
| Company | Market Cap | Price |
|---|---|---|
|
BSX
Boston Scientific Corporation
Neuromodulation devices including Intracept intraosseous nerve ablation system.
|
$144.50B |
$97.02
-0.72%
|
|
SYK
Stryker Corporation
OptaBlate BVN system is a neuromodulation/pain-management device.
|
$139.17B |
$362.97
-0.38%
|
|
MDT
Medtronic plc
Neuromodulation Devices cover the spine and brain stimulation technologies (e.g., Inceptiv, Percept) highlighted in the pipeline.
|
$130.01B |
$101.62
-0.36%
|
|
GMED
Globus Medical, Inc.
Neuromodulation devices via Nevro spinal cord stimulation platform and expansion.
|
$12.30B |
$90.72
+2.23%
|
|
INSP
Inspire Medical Systems, Inc.
Inspire V is a neuromodulation device designed to treat obstructive sleep apnea, representing Inspire's core product category.
|
$4.05B |
$136.74
-2.35%
|
|
LIVN
LivaNova PLC
Directly manufactures/distributes Neuromodulation Devices, including VNS Therapy and proximal hypoglossal nerve stimulation systems.
|
$3.46B |
$63.45
-0.70%
|
|
ATEC
Alphatec Holdings, Inc.
SafeOp neural monitoring systems used during spine surgery.
|
$3.17B |
$21.48
+0.92%
|
|
ITGR
Integer Holdings Corporation
Neuromodulation devices are a high-growth served market for Integer and align with its product portfolio.
|
$2.45B |
$70.06
-0.79%
|
|
PCRX
Pacira BioSciences, Inc.
IOvera's mechanism relates to neuromodulation/nerve-targeted therapy, aligning with Neuromodulation Devices.
|
$1.08B |
$24.00
+0.08%
|
|
BVS
Bioventus Inc.
Peripheral Nerve Stimulation products (TalisMann, StimTrial) are neuromodulation devices.
|
$586.19M |
$7.16
-6.10%
|
|
NPCE
NeuroPace, Inc.
Core product Neuromodulation device (RNS System) delivering brain-responsive, on-demand therapy for drug-resistant epilepsy.
|
$542.54M |
$16.46
-2.98%
|
|
AVNS
Avanos Medical, Inc.
The RFA portfolio (ESENTEC, TRIDENT, COOLIEF) places Avanos in the neuromodulation devices category.
|
$522.49M |
$11.26
+1.17%
|
|
BWAY
BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
|
$287.05M |
$17.18
+0.29%
|
|
OBIO
Orchestra BioMed Holdings, Inc.
AVIM therapy uses neuromodulation to affect autonomic nervous system responses, fitting Neuromodulation Devices.
|
$237.40M |
$4.47
-4.49%
|
|
CVRX
CVRx, Inc.
CVRx's Barostim is a neuromodulation device (implantable) that modulates the autonomic nervous system via baroreflex activation for heart failure.
|
$236.67M |
$9.07
-2.94%
|
|
NYXH
Nyxoah S.A.
Genio is a neuromodulation implant system (implantable medical device) for obstructive sleep apnea.
|
$168.16M |
$4.82
+0.10%
|
|
STIM
Neuronetics, Inc.
NeuroStar Advanced Therapy System is a non-invasive neuromodulation device; the direct product of the company.
|
$89.27M |
$1.38
-5.17%
|
|
VANI
Vivani Medical, Inc.
Vivani's Neurostimulation division (Cortigent) assets exist and are being spun off, representing Neuromodulation Devices.
|
$82.94M |
$1.42
+0.35%
|
|
ECOR
electroCore, Inc.
Directly markets and sells neuromodulation medical devices (gammaCore, Quell, Truvaga, Sparrow Ascent, TAC-STIM).
|
$36.55M |
$4.94
-0.20%
|
|
NMTC
NeuroOne Medical Technologies Corporation
Core product category: neuromodulation devices used to treat epilepsy and pain via brain stimulation and ablation.
|
$35.47M |
$0.69
+2.24%
|
|
ZYXI
Zynex, Inc.
NexWave and TensWave are neuromodulation/electrotherapy devices, placing the company in the neuromodulation devices category.
|
$26.96M |
$0.91
-11.87%
|
|
NRXS
NeurAxis, Inc.
Core product line: Neuromodulation devices (IB-Stim PENFS).
|
$26.32M |
$2.65
-2.21%
|
|
COCH
Envoy Medical, Inc.
Cochlear implants operate by neuromodulating auditory pathways, classifying them as neuromodulation devices.
|
$18.12M |
$0.85
+0.27%
|
|
NXL
Nexalin Technology, Inc.
Core product is non-invasive neuromodulation devices for brain stimulation (Gen-2 SYNC, Gen-3 HALO).
|
$16.90M |
$0.97
+0.78%
|
|
AMIX
Autonomix Medical, Inc. Common Stock
Core platform is a catheter-based Neuromodulation Device designed to sense and ablate peripheral nerves.
|
$4.35M |
$0.84
-2.94%
|
|
HSDT
Solana Company
PoNS is a non-invasive neuromodulation device produced by the company for gait and balance rehabilitation.
|
$4.16M |
$3.88
-7.62%
|
Loading company comparison...
Loading industry trends...
Loading research report...
